Literature DB >> 22085694

Impaired long-trace eyeblink conditioning in a Tg2576 mouse model of Alzheimer's disease.

Yasushi Kishimoto1, Ikuko Oku, Atsuko Nishigawa, Akiko Nishimoto, Yutaka Kirino.   

Abstract

Eyeblink conditioning has been used for assessing cognitive performance in cases of human neurodegenerative diseases including Alzheimer's disease (AD). Here, we tested and compared the delay and long-trace interval (TI=500ms) eyeblink conditionings in a Tg2576 mouse model of AD, at the age of 3, 6, and 12 months. Tg2576 mice exhibited significant impairment in trace conditioning at 6 months of age. In contrast, delay conditioning was not impaired in Tg2576 mice even at 12 months. These findings indicate that the long-TI eyeblink conditioning is more susceptible to age-related cognitive deterioration than delay conditioning in Tg2576 mice. The long-trace eyeblink conditioning could be a potential tool for detecting early cognitive deficits in AD mouse model.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085694     DOI: 10.1016/j.neulet.2011.10.071

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Age-dependent impairment of eyeblink conditioning in prion protein-deficient mice.

Authors:  Yasushi Kishimoto; Moritoshi Hirono; Ryuichiro Atarashi; Suehiro Sakaguchi; Tohru Yoshioka; Shigeru Katamine; Yutaka Kirino
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

2.  Implicit Memory in Monkeys: Development of a Delay Eyeblink Conditioning System with Parallel Electromyographic and High-Speed Video Measurements.

Authors:  Yasushi Kishimoto; Shigeyuki Yamamoto; Kazutaka Suzuki; Haruyoshi Toyoda; Masanobu Kano; Hideo Tsukada; Yutaka Kirino
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

3.  Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol.

Authors:  Yasushi Kishimoto; Barbara Cagniard; Maya Yamazaki; Junko Nakayama; Kenji Sakimura; Yutaka Kirino; Masanobu Kano
Journal:  Front Behav Neurosci       Date:  2015-06-02       Impact factor: 3.558

Review 4.  Hippocampal Non-Theta-Contingent Eyeblink Classical Conditioning: A Model System for Neurobiological Dysfunction.

Authors:  Joseph J Cicchese; Stephen D Berry
Journal:  Front Psychiatry       Date:  2016-02-12       Impact factor: 4.157

5.  mGluR1 in cerebellar Purkinje cells is essential for the formation but not expression of associative eyeblink memory.

Authors:  Harumi Nakao; Yasushi Kishimoto; Kouichi Hashimoto; Kazuo Kitamura; Miwako Yamasaki; Kazuki Nakao; Masahiko Watanabe; Masanobu Kano; Yutaka Kirino; Atsu Aiba
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

6.  mGluR5 Is Substitutable for mGluR1 in Cerebellar Purkinje Cells for Motor Coordination, Developmental Synapse Elimination, and Motor Learning.

Authors:  Maria Harbers; Harumi Nakao; Takaki Watanabe; Kyoko Matsuyama; Shoichi Tohyama; Kazuki Nakao; Yasushi Kishimoto; Masanobu Kano; Atsu Aiba
Journal:  Cells       Date:  2022-06-23       Impact factor: 7.666

7.  Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment.

Authors:  Masahisa Matsumura; Kana Sato; Takashi Kubota; Yasushi Kishimoto
Journal:  Data Brief       Date:  2021-05-12

Review 8.  Eyeblink Conditioning and Novel Object Recognition in the Rabbit: Behavioral Paradigms for Assaying Psychiatric Diseases.

Authors:  Craig Weiss; John F Disterhoft
Journal:  Front Psychiatry       Date:  2015-10-07       Impact factor: 4.157

9.  Impairment of cerebellar long-term depression and GABAergic transmission in prion protein deficient mice ectopically expressing PrPLP/Dpl.

Authors:  Yasushi Kishimoto; Moritoshi Hirono; Ryuichiro Atarashi; Suehiro Sakaguchi; Tohru Yoshioka; Shigeru Katamine; Yutaka Kirino
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.